Molecular Diagnostics
World-First Bedside Genetic Test Identifies Susceptibility to Deafness in Newborn Babies
A new bedside machine takes just 25 minutes to identify whether a critically ill baby admitted to intensive care has a gene that could result in permanent hearing loss if they are treated with a common emergency antibiotic. More...05 Apr 2022
World-First Bedside Genetic Test Identifies Susceptibility to Deafness in Newborn Babies
A new bedside machine takes just 25 minutes to identify whether a critically ill baby admitted to intensive care has a gene that could result in permanent hearing loss if they are treated with a common emergency antibiotic. More...05 Apr 2022
Blood Test to Detect Protein Biomarkers Identified Using Breast Milk Could Enable Breast Cancer Screening
A simple blood test for women of all ages and risk levels could one day be possible thanks to a new set of protein biomarkers identified by researchers using breast milk. The newly identified biomarkers are for a specific type of cancer called invasive ductal carcinoma (IDC), one of the most common types of breast cancers, but the approach could be used to identify biomarkers for other types of breast cancer as well. More...05 Apr 2022
Liquid Biopsy Can Detect Recurrent Breast Cancer and Monitor Progression
A new study has found that liquid biopsy performed on serum samples taken from breast cancer patients can provide increasingly accurate information on cancer progression and enable earlier detection of cancer recurrence. More...31 Mar 2022
Thermo Fisher Launches CE-IVD Marked NGS Instrument for Diagnostic Testing
Thermo Fisher Scientific (Waltham, MA, USA) has launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in as little as a single day. Designed for use in clinical laboratories, the fully validated system enables users to perform both diagnostic testing and clinical research on a single instrument. More...31 Mar 2022
.jpg)
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Pipette Calibration System
Artel PCS®
New
Thyroid Test
Anti-Thyroid EIA Test
In Other News
Siemens sNfL Blood Test Predicts Risk of MS Disease Activity
Rapid Test Predicts Sepsis Soon After Infection and Before Organ Damage
NGS Panels Detect RNA and DNA Cancer Biomarkers in Single Assay
Novel System to Accelerate Development of New Diagnostic Tests
Urine Liquid Biopsy Test Detects Molecular Evidence of Prostate Cancer
BDNF Risk Variant Linked to Brain Inflammation in RRMS Patients
Blood Levels of Glial Fibrillary Acidic Protein Predict Dementia Risk in Older Mexican Americans
A Minimally Invasive PCR Test for Diagnosis of Oral Cancer
Enzyme-Based Point-of-Care Test Could Rapidly Identify Stroke Patients upon Arrival at Hospital
New Antibody Test Diagnoses Multiple Sclerosis in 20 Minutes
An Extracellular Vesicle-based Liquid Biopsy for Early Cancer Detection
Cerebrospinal Fluid Liquid Biopsy for Diagnosis of Metastatic Breast Cancer
Novel Painless Test Massively Simplifies Diagnosis of Allergies and Predicts Success of Immunotherapy
Genetic Overlap Found for Ovarian Cancer Subtypes and Endometriosis
Personalized Tumor-Informed Assay Helps Patients Get Ahead of Cancer
Worm-on-a-Chip Device Could Noninvasively Diagnose Early-Stage Cancer
Pediatric Cancer Sequencing Expands Relapse Treatment Options
Alpha-Synuclein Skin Deposits Characterize Parkinson’s Disease Patients
Blood Plasma Biomarkers Could Improve Diagnostic Tests for Alzheimer's Disease
Groundbreaking DNA Test Evaluates Biomarkers in 517 Cancer-Relevant Genes across 30 Types of Solid Tumors
Single Cell Characterization Acral Melanoma Identifies Novel Targets for Immunotherapy
New Test Could Help Diagnose Lyme Disease Sooner and Determine Treatment Efficacy
Expression, Microbiome Features Provide Pre-Treatment Lung Function Clues for Pediatric Patients
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
